As per DelveInsight’s assessment, globally, about 75+ key pharma and biotech companies are working on 75+ pipeline drugs in the Duchenne Muscular Dystrophy (DMD) therapeutics landscape based on ...

With PMDA approval now secured in Japan, MedHub-AI is progressing rapidly toward regulatory clearance in the United States. The company is in the final stages of its FDA 510k process and expects ...

DELHI, DELHI, INDIA, July 9, 2024 /EINPresswire / -- DelveInsight's,“ER+/ HER2-VE Breast Cancer Pipeline Insight 2024” report provides comprehensive insights about 40+ companies and 50 ...